IL-6 is also associated with mortality in acute renal failure (ARF) [18–20] and may be useful for predicting the clinical outcomes in patients with AKI, but supporting evidence adapted to the current KDIGO criteria are lacking. Here, IL6 is linked to acute kidney injury.